Armstrong Advisory Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24K Hold
90
﹤0.01% 890
2026
Q1
$1.26K Hold
90
﹤0.01% 911
2025
Q4
$1.01K Hold
90
﹤0.01% 915
2025
Q3
$1.04K Hold
90
﹤0.01% 897
2025
Q2
$1.1K Hold
90
﹤0.01% 873
2025
Q1
$1.43K Hold
90
﹤0.01% 799
2024
Q4
$1.43K Hold
90
﹤0.01% 799
2024
Q3
$2.16K Hold
90
﹤0.01% 728
2024
Q2
$1.79K Hold
90
﹤0.01% 740
2024
Q1
$2.02K Hold
90
﹤0.01% 716
2023
Q4
$2.02K Hold
90
﹤0.01% 716
2023
Q3
$1.82K Hold
90
﹤0.01% 786
2023
Q2
$2.3K Hold
90
﹤0.01% 732
2023
Q1
$2.68K Sell
90
-11
-11% -$319 ﹤0.01% 693
2022
Q4
$2.73K Buy
+101
New +$2.47K ﹤0.01% 715

Other funds holding AVNS

Armstrong Advisory Group's AVNS Position: Q2 2026 in Review

Armstrong Advisory Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 90 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Armstrong Advisory Group first reported a position in AVNS in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.73K in Q4 2022. 26 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Armstrong Advisory Group held 90 shares of Avanos Medical worth $2.24K as of Q2 2026.
  • Armstrong Advisory Group left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #890 holding.
  • Armstrong Advisory Group first reported a position in Avanos Medical in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Avanos Medical position peaked at $2.73K in Q4 2022.
  • 26 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.